D. E. Shaw & Co., Inc. Penumbra Inc Transaction History

D. E. Shaw & Co., Inc.

$125 Billion
Q2 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Penumbra Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 11,400 shares of PEN stock, worth $2.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,400

Previous 11,400 -0.0%

Holding current value

$2.84 Million

Previous $3.05 Million 4.04%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$237.28 - $303.76 $181,281 - $232,072	764 Added 11.2%	7,586 $2.03 Million
Q4 2024 Feb 14, 2025	SELL	$190.97 - $253.66 $343,364 - $456,080	-1,798 Reduced 20.86%	6,822 $1.62 Million
Q3 2024 Nov 14, 2024	BUY	$163.64 - $210.12 $8,672 - $11,136	53 Added 0.62%	8,620 $1.67 Million
Q2 2024 Aug 14, 2024	BUY	$172.27 - $223.95 $1.21 Million - $1.57 Million	7,008 Added 449.52%	8,567 $1.54 Million
Q1 2024 May 15, 2024	BUY	$220.09 - $273.15 $343,120 - $425,840	1,559 New	1,559 $347,000
Q3 2023 Nov 14, 2023	SELL	$240.69 - $338.77 $3.75 Million - $5.28 Million	-15,578 Reduced 93.97%	1,000 $241,000
Q2 2023 Aug 14, 2023	BUY	$271.54 - $344.06 $4.5 Million - $5.7 Million	16,578 New	16,578 $5.7 Million
Q3 2022 Nov 14, 2022	BUY	$120.36 - $205.88 $758,990 - $1.3 Million	6,306 New	6,306 $1.2 Million
Q1 2022 May 16, 2022	SELL	$187.51 - $283.98 $74,816 - $113,308	-399 Reduced 19.2%	1,679 $373,000
Q4 2021 Feb 14, 2022	SELL	$238.08 - $288.0 $657,576 - $795,456	-2,762 Reduced 57.07%	2,078 $597,000
Q3 2021 Nov 15, 2021	SELL	$250.72 - $291.24 $634,572 - $737,128	-2,531 Reduced 34.34%	4,840 $1.29 Million
Q3 2020 Nov 16, 2020	BUY	$185.27 - $238.73 $1.37 Million - $1.76 Million	7,371 New	7,371 $1.43 Million
Q4 2019 Feb 14, 2020	SELL	$134.81 - $177.8 $720,289 - $949,985	-5,343 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$131.82 - $183.4 $25.2 Million - $35 Million	-190,804 Reduced 97.28%	5,343 $719,000
Q2 2019 Aug 14, 2019	BUY	$124.65 - $167.39 $1.4 Million - $1.88 Million	11,240 Added 6.08%	196,147 $31.4 Million
Q1 2019 May 15, 2019	SELL	$115.84 - $160.31 $10.8 Million - $14.9 Million	-93,068 Reduced 33.48%	184,907 $27.2 Million
Q4 2018 Feb 14, 2019	BUY	$113.42 - $156.48 $8.23 Million - $11.4 Million	72,582 Added 35.34%	277,975 $34 Million
Q3 2018 Nov 14, 2018	SELL	$121.55 - $156.8 $4.04 Million - $5.21 Million	-33,230 Reduced 13.93%	205,393 $30.7 Million
Q2 2018 Aug 14, 2018	BUY	$112.2 - $165.95 $22.6 Million - $33.5 Million	201,748 Added 547.11%	238,623 $33 Million
Q1 2018 May 15, 2018	BUY	$84.6 - $126.1 $551,507 - $822,045	6,519 Added 21.48%	36,875 $4.27 Million
Q4 2017 Feb 14, 2018	BUY	$91.55 - $115.85 $1.21 Million - $1.53 Million	13,217 Added 77.12%	30,356 $2.86 Million
Q3 2017 Nov 14, 2017	BUY	$79.65 - $90.3 $1.37 Million - $1.55 Million	17,139	17,139 $1.55 Million

Others Institutions Holding PEN

# of Institutions

501

Shares Held

30M

Call Options Held

266K

Put Options Held

59.2K

View Full List

About Penumbra Inc

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.43B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

More about PEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account